Pages that link to "Q30353416"
Jump to navigation
Jump to search
The following pages link to Pablo Villoslada (Q30353416):
Displaying 50 items.
- European population substructure: clustering of northern and southern populations (Q21092502) (← links)
- Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study (Q21560983) (← links)
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (Q24635370) (← links)
- European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups (Q24648104) (← links)
- Transcription-based prediction of response to IFNbeta using supervised computational methods (Q24809619) (← links)
- The APOSTEL recommendations for reporting quantitative optical coherence tomography studies (Q26745975) (← links)
- Acute optic neuritis: Unmet clinical needs and model for new therapies (Q26799784) (← links)
- Update on biomarkers in neuromyelitis optica (Q26799789) (← links)
- Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine (Q27317185) (← links)
- Restoring immune tolerance in neuromyelitis optica: Part II (Q28070136) (← links)
- Restoring immune tolerance in neuromyelitis optica: Part I (Q28072382) (← links)
- Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder (Q28085378) (← links)
- Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways (Q28299922) (← links)
- Steady state detection of chemical reaction networks using a simplified analytical method (Q28474196) (← links)
- Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation (Q28486241) (← links)
- Knowledge retrieval from PubMed abstracts and electronic medical records with the Multiple Sclerosis Ontology (Q28543366) (← links)
- Erratum to: Making sense of big data in health research: towards an EU action plan (Q28596148) (← links)
- [Recommendations for the clinical use of motor evoked potentials in multiple sclerosis]. (Q30569210) (← links)
- Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. (Q30649660) (← links)
- Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach (Q31138740) (← links)
- A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases (Q33306704) (← links)
- Analysis and application of European genetic substructure using 300 K SNP information (Q33315564) (← links)
- A computational analysis of protein-protein interaction networks in neurodegenerative diseases (Q33345563) (← links)
- Allele-specific gene expression is widespread across the genome and biological processes (Q33398045) (← links)
- Computational disease modeling - fact or fiction? (Q33460729) (← links)
- UJA-3DFD: a program to compute the 3D fractal dimension from MRI data (Q33695361) (← links)
- Burden of neurological diseases in the US revealed by web searches (Q33713117) (← links)
- Biomarkers for multiple sclerosis (Q33770333) (← links)
- Computational classifiers for predicting the short-term course of Multiple sclerosis (Q33925740) (← links)
- Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis (Q33962548) (← links)
- Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis (Q34142459) (← links)
- Color vision is strongly associated with retinal thinning in multiple sclerosis. (Q34145469) (← links)
- Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism. (Q34195644) (← links)
- Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination (Q34279716) (← links)
- Role of nerve growth factor and other trophic factors in brain inflammation (Q34286996) (← links)
- Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. (Q34376913) (← links)
- Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. (Q34479121) (← links)
- Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. (Q34624396) (← links)
- Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity (Q34687561) (← links)
- Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. (Q34736044) (← links)
- Transient oscillatory dynamics of interferon beta signaling in macrophages (Q34803273) (← links)
- Memantine induces reversible neurologic impairment in patients with MS. (Q34906988) (← links)
- Multiple sclerosis susceptibility genes: associations with relapse severity and recovery (Q35018274) (← links)
- Association of multiple sclerosis susceptibility variants and early attack location in the CNS (Q35018315) (← links)
- Increased expression of cystine/glutamate antiporter in multiple sclerosis (Q35052754) (← links)
- Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. (Q36613374) (← links)
- Analysis of antibodies to surface epitopes of contactin-2 in multiple sclerosis (Q36707237) (← links)
- Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes (Q36836384) (← links)
- Immunotherapy for neurological diseases (Q37183822) (← links)
- A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation (Q37384508) (← links)